Knife's edge: Balancing immunogenicity and reactogenicity in mRNA vaccines

Area of Science:

• Immunology
• Vaccinology
• Molecular Biology

Background:

• Messenger RNA (mRNA) technology has revolutionized vaccine development, notably during the COVID-19 pandemic.
• First-generation COVID-19 mRNA vaccines demonstrated high efficacy and immunogenicity but exhibit limited durability.
• Reported side effects range from mild reactogenicity to rare severe adverse events.

Purpose of the Study:

• To provide an overview of immune responses to COVID-19 mRNA vaccines.
• To offer mechanistic insights into documented adverse effects.
• To discuss the future potential and challenges of mRNA vaccine platforms.

Main Methods:

• Literature review of studies on COVID-19 mRNA vaccines.
• Analysis of data on immunogenicity (humoral and cell-mediated).
• Examination of reported vaccine side effects and safety profiles.

Main Results:

• COVID-19 mRNA vaccines induce robust, albeit potentially less durable, immune responses.
• A spectrum of adverse effects has been documented, varying in severity.
• Balancing vaccine immunogenicity with acceptable safety profiles remains a key challenge.

Conclusions:

• mRNA vaccine technology holds significant promise for future therapeutics and vaccines.
• Further research is needed to enhance durability and mitigate adverse effects.
• Optimizing mRNA vaccine design is crucial for long-term public health impact.